BeStock  
Stocks › TARS

Tarsus Pharmaceuticals TARS

US equityMarket cap rank #2378
$74.46 +$1.46 (+1.99%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $74.46 0.00%
Open$73.22
Prev close$73.00
Day range$72.76 – $75.00
Volume939.6K
Market cap$3.48B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts10
Average target$100.11+34.5% vs. price
  • Buy 100%
Low $88.00Now $74.46Avg $100.11High $116.00

Recent rating changes

The last 20 actions on file set price targets from $88.00 to $116.00, averaging $99.50.

DateFirmRatingTarget
2 Oct 2026 Oppenheimer BUY $100.00
24 Sep 2026 Goldman Sachs BUY $116.00
16 Sep 2026 Barclays BUY $110.00
8 Sep 2026 Jefferies BUY $105.00
12 Aug 2026 William Blair BUY –
12 Aug 2026 Oppenheimer BUY $100.00
11 Aug 2026 Mizuho Securities BUY $100.00
8 Aug 2026 LifeSci Capital BUY $104.00
7 Aug 2026 LifeSci Capital BUY $104.00
7 Aug 2026 Mizuho Securities BUY $100.00
7 Aug 2026 H.C. Wainwright BUY $88.00
4 Aug 2026 Mizuho Securities BUY $98.00
31 Jul 2026 Mizuho Securities BUY $98.00
21 Jul 2026 Guggenheim BUY $89.00
21 Jul 2026 Oppenheimer BUY $97.00
14 Jul 2026 William Blair BUY –
14 Jul 2026 Mizuho Securities BUY $100.00
14 Jul 2026 Guggenheim BUY $90.00
14 Jul 2026 Oppenheimer BUY $97.00
13 Jul 2026 LifeSci Capital BUY $95.00

Discussion

No comments yet — be the first to weigh in on TARS.

Leave a comment

Scroll to Top